MEF2D
Myocyte-specific enhancer factor 2D
Also known as: MEF2D_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14814
- Gene
- MEF2D
- Ensembl
- ENSG00000116604
- Chromosome
- 1
- Canonical length
- 521 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
Canonical amino-acid sequenceUniProt
521 residues, UniProt reviewed canonical sequence.
>Q14814|MEF2D
1 MGRKKIQIQR ITDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNH SNKLFQYAST
61 DMDKVLLKYT EYNEPHESRT NADIIETLRK KGFNGCDSPE PDGEDSLEQS PLLEDKYRRA
121 SEELDGLFRR YGSTVPAPNF AMPVTVPVSN QSSLQFSNPS GSLVTPSLVT SSLTDPRLLS
181 PQQPALQRNS VSPGLPQRPA SAGAMLGGDL NSANGACPSP VGNGYVSARA SPGLLPVANG
241 NSLNKVIPAK SPPPPTHSTQ LGAPSRKPDL RVITSQAGKG LMHHLTEDHL DLNNAQRLGV
301 SQSTHSLTTP VVSVATPSLL SQGLPFSSMP TAYNTDYQLT SAELSSLPAF SSPGGLSLGN
361 VTAWQQPQQP QQPQQPQPPQ QQPPQPQQPQ PQQPQQPQQP PQQQSHLVPV SLSNLIPGSP
421 LPHVGAALTV TTHPHISIKS EPVSPSRERS PAPPPPAVFP AARPEPGDGL SSPAGGSYET
481 GDRDDGRGDF GPTLGLLRPA PEPEAEGSAV KRMRLDTWTL KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MEF2D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.69
- Highest tissue expression
- 158 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 158 nTPM
- blood vessel: 92 nTPM
- bone marrow: 75 nTPM
- tongue: 65 nTPM
- heart muscle: 51 nTPM
- retina: 46 nTPM
Single-cell type
- neutrophils: 259 nCPM
- cone photoreceptor cells: 217 nCPM
- pdcs: 159 nCPM
- rod photoreceptor cells: 130 nCPM
- myonuclei: 127 nCPM
- vascular smooth muscle cells: 127 nCPM
Immune cell
- plasmacytoid DC: 5.5 nTPM
- neutrophil: 5.1 nTPM
- eosinophil: 1.5 nTPM
- MAIT T-cell: 1.4 nTPM
- non-classical monocyte: 1.4 nTPM
- classical monocyte: 1.3 nTPM
Brain region
- cerebral cortex: 113 nTPM
- cerebellum: 108 nTPM
- hippocampal formation: 106 nTPM
- basal ganglia: 105 nTPM
- amygdala: 96 nTPM
- white matter: 91 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.25
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult heart development
- apoptotic process
- cell differentiation
- muscle organ development
- nervous system development
- positive regulation of transcription by RNA polymerase II
- positive regulation of vascular associated smooth muscle cell proliferation
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- histone deacetylase binding
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MEF2D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MEF2D as an antibody target. Whether an autoantibody or antibody against MEF2D could matter depends on whether native MEF2D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MEF2D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MEF2D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...